Papers

 

  • H. I. Brunner, N. Ruperto, N. Tzaribachev, G. Horneff, V. G. Chasnyk, V. Panaviene, C. Abud-Mendoza, A. Reiff, E. Alexeeva, N. Rubio-Pérez, V. Keltsev, D. J. Kingsbury, M. del Rocio Maldonado Velázquez, I. Nikishina, E. D. Silverman, R. Joos, E. Smolewska, M. Bandeira, K. Minden, A. van Royen-Kerkhof, W. Emminger, I. Foeldvari, B. R. Lauwerys, F. Sztajnbok, K. E. Gilmer, Z. Xu, J. H. Leu, L. Kim, S. L. Lamberth, M. J. Loza, D. J. Lovell and A. Martini.
    Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
    Annals of the Rheumatic Diseases, (), 2017. [ http ]

 

  • F. Minoia, F. Bovis, S. Daví, A. Insalaco, K. Lehmberg, S. Shenoi, S. Weitzman, G. Espada, Y.-J. Gao, J. Anton, T. Kitoh, O. Kasapcopur, H. Sanner, R. Merino, I. Astigarraga, M. Alessio, M. Jeng, V. Chasnyk, K. E. Nichols, Z. Huasong, C. Li, C. Micalizzi, N. Ruperto, A. Martini, R. Q. Cron, A. Ravelli and A. Horne.
    Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
    The Journal of Pediatrics, 189 72 - 78.e3 (Supplement C), 2017. [ http ]

 

  • N. Ruperto, H. I. Brunner, D. J. Lovell and A. Martini.
    Extrapolation or controlled trials in paediatrics: the current dilemma
    Archives of Disease in Childhood, 102 949-951 (10), 2017. [ http ]

 

  • A. Ravelli, F. Minoia, S. Daví, A. Horne, F. Bovis, A. Pistorio, M. Aricó, T. Avcin, E. M. Behrens, F. De Benedetti, L. Filipovich, A. A. Grom, J.-I. Henter, N. T. Ilowite, M. B. Jordan, R. Khubchandani, T. Kitoh, K. Lehmberg, D. J. Lovell, P. Miettunen, K. E. Nichols, S. Ozen, J. Pachlopnick-Schmid, A. V. Ramanan, R. Russo, R. Schneider, G. Sterba, Y. Uziel, C. Wallace, C. Wouters, N. Wulffraat, E. Demirkaya, H. I. Brunner, A. Martini, N. Ruperto, R. Q. Cron, on behalf of the Pediatric Rheumatology International Trials Organization, the Childhood Arthritis & Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group and the Histiocyte Society.
    Development and initial validation of classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
    Arthritis & Rheumatology, 68 566–576 (3), 2016. [ http ]

 

  • A. A. Grom, N. T. Ilowite, V. Pascual, H. I. Brunner, A. Martini, D. Lovell, N. Ruperto, for the Paediatric Rheumatology International Trials Organisation, the Pediatric Rheumatology Collaborative Study Group, K. Leon, K. Lheritier and K. Abrams.
    Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
    Arthritis & Rheumatology, 68 218-228 (1), 2016. [ http ]

 

  • F. De Benedetti, H. Brunner, N. Ruperto, R. Schneider, R. Xavier, R. Allen, D. E. Brown, J. Chaitow, M. Pardeo, G. Espada, V. Gerloni, B. L. Myones, J. W. Frane, J. Wang, T. H. Lipman, K. N. Bharucha, A. Martini, D. Lovell, for the Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group.
    Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial
    Arthritis & Rheumatology, 67 840-848 (3), 2015. [ http ]

 

  • D. J. Lovell, N. Ruperto, R. Mouy, E. Paz, N. Rubio-Pérez, C. A. Silva, C. Abud-Mendoza, R. Burgos-Vargas, V. Gerloni, J. A. Melo-Gomes, C. Saad-Magalhaes, J. Chavez-Corrales, C. Huemer, A. Kivitz, F. J. Blanco, I. Foeldvari, M. Hofer, H.-I. Huppertz, C. Job Deslandre, K. Minden, M. Punaro, A. J. Block, E. H. Giannini, A. Martini, for the Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation.
    Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years
    Arthritis & Rheumatology, 67 2759-2770 (10), 2015. [ http ]

 

  • H. I. Brunner, N. Ruperto, Z. Zuber, C. Keane, O. Harari, A. Kenwright, P. Lu, R. Cuttica, V. Keltsev, R. M. Xavier, I. Calvo, I. Nikishina, N. Rubio-Pérez, E. Alexeeva, V. Chasnyk, G. Horneff, V. Opoka-Winiarska, P. Quartier, C. A. Silva, E. Silverman, A. Spindler, E. Baildam, M. L. Gámir, A. Martin, C. Rietschel, D. Siri, E. Smolewska, D. Lovell, A. Martini, F. De Benedetti, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
    Annals of the Rheumatic Diseases, 74 1110-1117 (6), 2015. [ http ]

 

  • D. J. Kingsbury, B. Bader-Meunier, G. Patel, V. Arora, J. Kalabic and H. Kupper.
    Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
    Clinical Rheumatology, 1-9 (), 2014. [ http ]

 

  • R. Sobel, D. Lovell, H. Brunner, J. Weiss, P. Morris, B. Gottlieb, E. Chalom, L. Jung, K. Onel, L. Petiniot, D. Goldsmith, K. Nanda, M. Shishov, S. Abramsky, J. Young, E. Giannini and the Pediatric Rheumatology Collaborative Study Group.
    Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the phase 4 registry
    Pediatric Rheumatology, 12 29 (1), 2014. [ http ]

 

  • M. Seid, B. Huang, S. Niehaus, H. I. Brunner and D. J. Lovell.
    Determinants of Health-Related Quality of Life in Children Newly Diagnosed With Juvenile Idiopathic Arthritis
    Arthritis Care & Research, 66 263-269 (2), 2014. [ http ]

 

  • S. Davi, F. Minoia, A. Pistorio, A. Horne, A. Consolaro, S. Rosina, F. Bovis, R. Cimaz, M. L. Gamir, N. T. Ilowite, I. Kone-Paut, S. K. Feitosa de Oliveira, D. McCurdy, C. A. Silva, F. Sztajnbok, E. Tsitsami, E. Unsal, J. E. Weiss, N. Wulffraat, M. Abinun, A. Aggarwal, M. T. Apaz, I. Astigarraga, F. Corona, R. Cuttica, G. D'Angelo, E. M. Eisenstein, S. Hashad, L. Lepore, V. Mulaosmanovic, S. Nielsen, S. Prahalad, D. Rigante, V. Stanevicha, G. Sterba, G. Susic, S. Takei, R. Trauzeddel, M. Zletni, N. Ruperto, A. Martini, R. Q. Cron, A. Ravelli and on behalf of the Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.
    Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
    Arthritis & Rheumatology, 66 2871-2880 (10), 2014. [ http ]

 

  • R. Mina, M. S. Klein-Gitelman, S. Nelson, B. A. Eberhard, G. Higgins, N. G. Singer, K. Onel, L. Tucker, K. M. O'Neil, M. Punaro, D. M. Levy, K. Haines, A. Martini, N. Ruperto, D. Lovell and H. I. Brunner.
    Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus
    Annals of the Rheumatic Diseases, 73 401-406 (2), 2014. [ http ]

 

  • C. A. Wallace, E. H. Giannini, S. J. Spalding, P. J. Hashkes, K. M. O'Neil, A. S. Zeft, I. S. Szer, S. Ringold, H. I. Brunner, L. E. Schanberg, R. P. Sundel, D. Milojevic, M. G. Punaro, P. Chira, B. S. Gottlieb, G. C. Higgins, N. T. Ilowite, Y. Kimura, S. Hamilton, A. Johnson, B. Huang, D. J. Lovell, for the Childhood Arthritis and R. R. Alliance.
    Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
    Arthritis & Rheumatism, 64 2012-2021 (6), 2012. [ http ]

 

  • F. De Benedetti, H. I. Brunner, N. Ruperto, A. Kenwright, S. Wright, I. Calvo, R. Cuttica, A. Ravelli, R. Schneider, P. Woo, C. Wouters, R. Xavier, L. Zemel, E. Baildam, R. Burgos-Vargas, P. Dolezalova, S. M. Garay, R. Merino, R. Joos, A. Grom, N. Wulffraat, Z. Zuber, F. Zulian, D. Lovell and A. Martini.
    Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
    New England Journal of Medicine, 367 2385-2395 (25), 2012. [ http ]

 

  • N. Ruperto, H. I. Brunner, P. Quartier, T. Constantin, N. Wulffraat, G. Horneff, R. Brik, L. McCann, O. Kasapcopur, L. Rutkowska-Sak, R. Schneider, Y. Berkun, I. Calvo, M. Erguven, L. Goffin, M. Hofer, T. Kallinich, S. K. Oliveira, Y. Uziel, S. Viola, K. Nistala, C. Wouters, R. Cimaz, M. A. Ferrandiz, B. Flato, M. L. Gamir, I. Kone-Paut, A. Grom, B. Magnusson, S. Ozen, F. Sztajnbok, K. Lheritier, K. Abrams, D. Kim, A. Martini and D. J. Lovell.
    Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
    New England Journal of Medicine, 367 2396-2406 (25), 2012. [ http ]

 

  • D. J. Lovell, M. H. Passo, T. Beukelman, S. L. Bowyer, B. S. Gottlieb, M. Henrickson, N. T. Ilowite, Y. Kimura, E. M. DeWitt, J. Segerman, L. D. Stein, J. Taylor, R. K. Vehe and E. H. Giannini.
    Measuring process of arthritis care: A proposed set of quality measures for the process of care in juvenile idiopathic arthritis
    Arthritis Care & Research, 63 10-16 (1), 2011. [ http ]

 

  • C. A. Wallace, E. H. Giannini, B. Huang, L. Itert, N. Ruperto, C. A. R. R. A. (CARRA), P. R. C. S. G. (PRCSG) and P. R. I. T. O. (PRINTO).
    American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
    Arthritis Care & Research, 63 929-936 (7), 2011. [ http ]

 

  • A. B. Gottlieb, K. Gordon, E. H. Giannini, P. Mease, J. Li, Y. Chon, J. Maddox, H. H. Weng, J. Wajdula, S. L. Lin and S. W. Baumgartner.
    Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications
    J Drugs Dermatol, 10 289-300 (), 2011. [ ]

 

  • A. Martini and D. Lovell.
    Juvenile idiopathic arthritis: state of the art and future perspectives
    Ann Rheum Dis, (7) 1260-3 (), 2010. [ http ]

 

  • N. Ruperto, D. Lovell, R. Cuttica, P. Woo, S. Meiorin, e. a. , P. R. I. T. O. (P. and P. R. C. S. G. (PRCSG).
    Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
    Ann Rheum Dis, 4 712-22 (), 2010. [ http ]

 

  • N. Ruperto, A. Pistorio, A. Ravelli, L. G. Rider, C. Pilkington, S. Oliveira, N. Wulffraat, G. Espada, S. Garay, R. Cuttica, M. Hofer, P. Quartier, J. Melo-Gomes, A. M. Reed, M. Wierzbowska, B. M. Feldman, M. Harjacek, H.-I. Huppertz, S. Nielsen, B. Flato, P. Lahdenne, H. Michels, K. J. Murray, L. Punaro, R. Rennebohm, R. Russo, Z. Balogh, M. Rooney, L. M. Pachman, C. Wallace, P. Hashkes, D. J. Lovell, E. H. Giannini, B. A. Gare and A. Martini.
    The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis
    Arthritis Care & Research, 62 1533-1541 (11), 2010. [ http ]

 

  • N. Ruperto, D. J. Lovell, T. Li, F. Sztajnbok, C. Goldenstein-Schainberg, M. Scheinberg, I. C. Penades, M. Fischbach, J. O. Alcala, P. J. Hashkes, C. Hom, L. Jung, L. Lepore, S. Oliveira, C. Wallace, M. Alessio, P. Quartier, E. Cortis, A. Eberhard, G. Simonini, I. Lemelle, E. C. Chalom, L. H. Sigal, A. Block, A. Covucci, M. Nys, A. Martini and E. H. Giannini.
    Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis
    Arthritis Care & Research, 62 1542-1551 (11), 2010. [ http ]

 

  • N. Ruperto, D. J. Lovell, P. Quartier, E. Paz, N. Rubio-Pérez, C. A. Silva, C. Abud-Mendoza, R. Burgos-Vargas, V. Gerloni, J. A. Melo-Gomes, C. Saad-Magalhães, J. Chavez-Corrales, C. Huemer, A. Kivitz, F. J. Blanco, I. Foeldvari, M. Hofer, G. Horneff, H.-I. Huppertz, C. Job-Deslandre, A. Loy, K. Minden, M. Punaro, A. F. Nunez, L. H. Sigal, A. J. Block, M. Nys, A. Martini and E. H. Giannini.
    Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
    Arthritis & Rheumatism, 62 1792-1802 (6), 2010. [ http ]

 

  • N. Ruperto, E. H. Giannini, A. Pistorio, H. I. Brunner, A. Martini and D. J. Lovell.
    Is it time to move to active comparator trials in juvenile idiopathic arthritis?: A review of current study designs
    Arthritis & Rheumatism, 62 3131-3139 (11), 2010. [ http ]

 

  • E. H. Giannini, N. T. Ilowite, D. J. Lovell, C. A. Wallace, C. E. Rabinovich, A. Reiff, G. Higgins, B. Gottlieb, P. R. C. S. Group, Y. Chon, N. Zhang and S. W. Baumgartner.
    Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis
    Arthritis & Rheumatism, 62 3259-3264 (11), 2010. [ http ]

 

  • S. Ozen, A. Pistorio, S. M. Iusan, A. Bakkaloglu, T. Herlin, R. Brik, A. Buoncompagni, C. Lazar, I. Bilge, Y. Uziel, D. Rigante, L. Cantarini, M. O. Hilario, C. A. Silva, M. Alegria, X. Norambuena, A. Belot, Y. Berkun, A. I. Estrella, A. N. Olivieri, M. G. Alpigiani, I. Rumba, F. Sztajnbok, L. Tambic-Bukovac, L. Breda, S. Al-Mayouf, D. Mihaylova, V. Chasnyk, C. Sengler, M. Klein-Gitelman, D. Djeddi, L. Nuno, C. Pruunsild, J. Brunner, A. Kondi, K. Pagava, S. Pederzoli, A. Martini, N. Ruperto and for the Paediatric Rheumatology International Trials Organisation (PRINTO).
    EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria
    Annals of the Rheumatic Diseases, 69 798-806 (5), 2010. [ http ]

 

  • P. McCroskery, C. A. Wallace, D. J. Lovell, S. Stryker, N. Chernyukhin, C. Blosch and D. J. Zack.
    Summary of worldwide pediatric malignancies reported after exposure to etanercept
    Pediatr Rheumatol Online J, 8 18 (), 2010. [ ]

 

  • S. Visvanathan, C. Wagner, J. C. Marini, D. J. Lovell, A. Martini, R. Petty, R. Cuttica, P. Woo, G. Espada, M. Gattorno, M. T. Apaz, E. Baildam, A. Fasth, V. Gerloni, P. Lahdenne, P. Quartier, R. Saurenmann, S. Travers, A. Mendelsohn, S. Xu, E. H. Giannini and N. Ruperto.
    The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial
    Pediatr Rheumatol Online J, 8 24 (), 2010. [ ]

 

  • I. Foeldvari, I. Szer, L. Zemel, D. Lovell and E. Giannini.
    A prospecitive study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis
    J Rheumatol, 36 (1) 174-82 (), 2009. [ http ]

 

  • G. Burmester, P. Mease, B. Dinkmans, K. Gordon and D. Lovell.
    Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
    Ann Rheum Dis, 1863-9 (), 2009. [ http ]

 

  • E. Giannini, N. Ilowite, D. Lovell, C. Wallace, C. Rabinovich and e. a. .
    Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis
    Arthritis Rheum, 60 2794-804 (9), 2009. [ http ]

 

  • N. Ruperto, A. Ravelli, A. Pistorio, V. Ferriani, I. Calvo, G. Ganser, J. Brunner, G. Dannecker, C. Silva, V. Stanevicha, R. Cate, L. van Suijlekom-Smit, O. Voygioyka, M. Fischbach, I. Foeldvari, O. Hilario, C. Modesto, R. Saurenmann, M. Sauvain, I. Scheibel, D. Sommelet, L. Tambic-Bukovac, R. Barcellona, R. Brik, S. Ehl, M. Jovanovic, J. Rovensky, F. Bagnasco, D. Lovell and A. Martini.
    The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: A prospective validation study.
    Arthritis Rheum, 59 (1) 4-13 (), 2008. [ ]

 

  • D. Lovell, N. Ruperto, S. Goodman, A. Reiff, L. Jung, K. Jarosova, D. Nemcova, R. Mouy, C. Sandborg, J. Bohnsack, D. Elewaut, I. Foeldvari, V. Gerloni, J. Rovensky, K. Minden, R. Vehe, L. Wagner-Weiner, G. Horneff, H. Huppertz, N. Olson, J. Medich, R. Carcereri-De-Prati, M. McIlraith, E. Giannini and A. Martini.
    A randomized, placebo-controlled trial of adalimumab with or without methotrexate in children with polyarticular juvenile rheumatoid arthritis
    N Engl J Med, Vol. 359 810-820 (No. 8), 2008. [ http ]

 

  • e. a. Lovell DJ, A. Reiff, N. Ilowite, C. Wallace, Y. Chon, S. Lin, S. Baumgartner and E. Giannini.
    Safety and Efficacy of up to 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
    Arthritis Rheum, 58 1496-504 ((5)), 2008. [ http ]

 

  • N. Ruperto, D. Lovell, E. Giannini and A. Martini.
    Efficacy and safety of abatacept in children with juvenile idiopathic arthritis: A randomized, double-blink, placebo controlled withdrawal trial
    Lancet, 372 383-391 (), 2008. [ http ]

 

  • N. Ruperto, D. Lovell and E. Giannini.
    Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
    Lancet, 372 (9636) 383-391 (), 2008. [ http ]

 

  • D. Lovell, N. Ruperto, S. Goodman and A. Reiff.
    Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
    N Engl J Med, 359 (8) 810-820 (), 2008. [ http ]

 

  • N. Ruperto, D. Lovell, R. Cuttica, N. Wilkinson, P. Woo, G. Espada, C. Wouters, E. Silverman, Z. Balogh, M. Henrickson, M. Apaz, E. Baildam, A. Fasth, V. Gerloni, P. Lahdenne, A. Prieur, A. Ravelli, R. Saurenmann, M. Gamir, N. Wulffraat, L. Marodi, R. Petty, R. Joos, F. Zulian, D. McCurdy, B. Myones, K. Nagy, P. Reuman, I. Szer, S. Travers, A. Beutler, G. Keenan, J. Clark, S. Visvanathan, A. Fasanmade, A. Raychaudhuri, A. Mendelsohn, A. Martini and E. Giannini.
    A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
    Arthritis Rheum, 56 3096-3106 (), 2007. [ ]

 

  • D. Lovell, A. Reiff and O. Jones.
    Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
    Arthritis & Rheumatism, 54 1987-1994 (), 2006. [ http ]

 

  • N. Ruperto, A. Ravelli, E. Castell, V. Gerloni, R. Haefner, C. Malattia, F. Kanakoudi-Tsakalidou, S. Nielsen, J. Bohnsack, D. Gibbas, R. Rennebohm, O. Voygioyka, Z. Balogh, L. Lepore, E. Macejkova, N. Wulffraat, S. Oliveira, R. Russo, A. Buoncompagni, M. O. Hilario, M. G. Alpigiani, M. Passo, D. J. Lovell, R. Merino, A. Martini and E. H. Giannini.
    Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study.
    Clin Exp Rheumatol, 24 599-605 (5), 2006. [ http ]

 

  • A. Reiff, D. Lovell, J. Van Adelsberg, M. Kiss, S. Goodman, M. Zavaler, P. Chen, J. Bolognese, P. Cavanaugh Jr, A. Reicin and E. Giannini.
    Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.
    J Rheumatol, 33 985-995 (5), 2006. [ http ]

 

  • C. Wallace, N. Ruperto and E. Giannini.
    Preliminary criteria for clinical remission for selected categories of juvenile idiopathic arthritis
    J Rheumatol, 31 2290-2294 (), 2004. [ http ]

 

  • L. Rider, E. Giannini, H. Brunner, N. Ruperto, L. James-Newton, A. Reed, P. Lachenbruch and F. Miller.
    International consensus on preliminary definitions of improvement in adult and juvenile myositis.
    Arthritis Rheum, 50 2281-90 (7), 2004. [ http ]

 

  • L. Rider, E. Giannini, M. Harris-Love, G. Joe, D. Isenberg, C. Pilkington, P. Lachenbruch and F. Miller.
    Defining Clinical Improvement in Adult and Juvenile Myositis
    J Rheumatol, 30 603-617 ((3)), 2003. [ http ]

 

  • D. Lovell, E. Giannini, A. Reiff, O. Jones, R. Schneider, J. Olson, L. Stein, A. Gedalia, N. Ilowite, C. Wallace, M. Lange, B. Finck and D. Burge.
    Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
    Arthritis Rheum, 48 218-26 (1), 2003. [ http ]

 

  • N. Ruperto, A. Ravelli, K. Murray, D. Lovell, B. Andersson-Gare, B. Feldman, S. Garay, W. Kuis, C. Machado, L. Pachman, A. Prieur, L. Rider, E. Silverman, E. Tsitsami, P. Woo, E. Giannini and A. Martini.
    Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.
    Rheumatology (Oxford), 42 1452-9 (12), 2003. [ http ]

 

  • H. Brunner, D. Lovell, B. Finck and E. Giannini.
    Preliminary definitions of disease flare in juvenile rheumatoid arthritis (JRA).
    J Rheumatol, 29 1058-64 (), 2002. [ ]

 

  • D. Lovell, E. Giannini, A. Reiff, G. Cawkwell, E. Silverman, J. Nocton, L. Stein, A. Gedalia, N. Ilowite, C. Wallace, J. Whitmore and B. Finck.
    Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
    N Engl J Med, 342 763-9 (11), 2000. [ http ]

 

  • D. J. Lovell, C. B. Lindsley, R. M. Rennebohm, S. H. Ballinger, S. L. Bowyer, E. H. Giannini, J. E. Hicks, J. E. Levinson, R. Mier, L. M. Pachman, M. H. Passo, M. D. Perez, A. M. Reed, K. N. Schikler, M. Smith, L. S. Zemel and L. G. Rider.
    Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
    Arthritis Rheum, 42 2213-9 (10), 1999. [ http ]

 

  • N. Ruperto, J. Levinson, A. Ravelli, E. Shear, B. Tague, K. Murray, A. Martini and E. Giannini.
    Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status
    J Rheumatol, 24 945-951 (), 1997. [ http ]

 

  • E. H. Giannini, N. Ruperto, A. Ravelli, D. J. Lovell, D. T. Felson and A. Martini.
    Preliminary definition of improvement in juvenile arthritis.
    Arthritis Rheum, 40 1202-9 (7), 1997. [ http ]

 

  • N. Ruperto and E. H. Giannini.
    Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials.
    Ann Rheum Dis, 55 73-5 (1), 1996. [ http ]

 

  • E. H. Giannini, D. J. Lovell, E. D. Silverman, R. P. Sundel, B. L. Tague and N. Ruperto.
    Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group.
    J Rheumatol, 23 919-24 (5), 1996. [ http ]

 

  • E. H. Giannini, D. J. Lovell and B. Hepburn.
    FDA draft guidelines for the clinical evaluation of anti-inflammatory and anti-rheumatic drugs in children. Executive summary.
    Arthritis Rheum, 38 715-8 (5), 1995. [ http ]

 

  • E. D. Silverman, G. D. Cawkwell, D. J. Lovell, R. M. Laxer, T. J. Lehman, M. H. Passo, L. S. Zemel and E. H. Giannini.
    Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group.
    J Rheumatol, 21 2353-8 (12), 1994. [ http ]

 

  • E. H. Giannini, J. T. Cassidy, E. J. Brewer, A. Shaikov, A. Maximov and N. Kuzmina.
    Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis.
    Semin Arthritis Rheum, 23 34-46 (1), 1993. [ http ]

 

  • E. H. Giannini, E. J. Brewer, N. Kuzmina, A. Shaikov, A. Maximov, I. Vorontsov, C. W. Fink, A. J. Newman, J. T. Cassidy and L. S. Zemel.
    Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
    N Engl J Med, 326 1043-9 (16), 1992. [ http ]

 

  • E. H. Giannini, K. S. Barron, C. H. Spencer, D. A. Person, J. Baum, B. H. Bernstein, D. W. Kredich, J. C. Jacobs, L. S. Zemel and D. Gibbas.
    Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial.
    J Rheumatol, 18 1240-2 (8), 1991. [ http ]

 

  • E. H. Giannini, E. J. J. Brewer, N. Kuzmina, A. Shaikov and B. Wallin.
    Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group.
    Arthritis Rheum, 33 466-76 (4), 1990. [ http ]

 

  • E. Giannini, E. Brewer, M. Miller, D. Gibbas, M. Passo, H. Hoyeraal, B. Bernstein, D. Person, C. Fink and L. Sawyer.
    Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
    J Pediatr, 117 645-52 (4), 1990. [ http ]

 

  • K. A. Sheerin, E. H. Giannini, E. J. J. Brewer and K. S. Barron.
    HLA-B27-associated arthropathy in childhood: Long-term clinical and diagnostic outcome.
    Arthritis Rheum, 31 1165-70 (9), 1988. [ http ]

 

  • C. van Kerckhove, E. H. Giannini and D. J. Lovell.
    Temporal patterns of response to D-penicillamine, hydroxychloroquine, and placebo in juvenile rheumatoid arthritis patients.
    Arthritis Rheum, 31 1252-8 (10), 1988. [ http ]

 

  • E. H. Giannini, E. J. Brewer, N. Kuzmina, L. Alekseev and B. P. Shokh.
    Characteristics of responders and nonresponders to slow-acting anti-rheumatic drugs (SAARDs) in juvenile rheumatoid arthritis.
    Arthritis Rheum, 31 15-20 (1), 1988. [ http ]

 

  • I. L. Arroyo, E. J. Brewer and E. H. Giannini.
    Arthritis/arthralgia and hypermobility of the joints in schoolchildren.
    J Rheumatol, 15 978-80 (6), 1988. [ http ]

 

  • E. H. Giannini and E. J. Brewer.
    Poor correlation between the erythrocyte sedimentation rate and clinical activity in juvenile rheumatoid arthritis.
    Clin Rheumatol, 6 197-201 (2), 1987. [ http ]

 

  • E. Giannini, E. Brewer, D. Person and X. He.
    Long-term auranofin therapy in patients with juvenile rheumatoid arthritis
    J Rheumatol, 314 1269-1276 (), 1986. [ http ]

 

  • E. Brewer, E. Giannini, N. Kuzmina and L. Alekseev.
    Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial.
    N Engl J Med, 314 1269-76 (20), 1986. [ http ]

 

  • A. Gedalia, D. A. Person, E. J. J. Brewer and E. H. Giannini.
    Hypermobility of the joints in juvenile episodic arthritis/arthralgia.
    J Pediatr, 107 873-6 (6), 1985. [ http ]

 

  • J. C. Bass, B. H. Athreya, E. J. Brewer, E. H. Giannini, D. P. Goldsmith, J. R. Hollister, D. W. Kredich, N. E. Brandstrup, J. J. Miller and L. M. Pachman.
    A once-daily anti-inflammatory drug, oxaprozin, in the treatment of juvenile rheumatoid arthritis. The Pediatric Rheumatology Collaborative Study Group.
    J Rheumatol, 12 384-6 (2), 1985. [ http ]

 

  • E. H. Giannini, E. J. Brewer and D. A. Person.
    Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.
    Ann Rheum Dis, 43 228-31 (2), 1984. [ http ]

 

  • D. J. Lovell, E. H. Giannini and E. J. J. Brewer.
    Time course of response to non-steroidal anti-inflammatory drugs in juvenile rheumatoid arthritis.
    Arthritis Rheum, 27 1433-7 (12), 1984. [ http ]

 

  • E. J. J. Brewer, E. H. Giannini and D. A. Person.
    Early experiences with auranofin in juvenile rheumatoid arthritis.
    Am J Med, 75 152-6 (6A), 1983. [ http ]

 

  • E. H. Giannini, E. J. J. Brewer and D. A. Person.
    Auranofin in the treatment of juvenile rheumatoid arthritis.
    J Pediatr, 102 138-41 (1), 1983. [ http ]

 

  • E. H. Giannini, D. A. Person, E. J. Brewer and D. B. Parks.
    Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis.
    J Rheumatol, 10 496-8 (3), 1983. [ http ]

 

  • E. Brewer, E. Giannini, J. Baum, J. Cassidy, C. Fink, V. Hanson, J. Jacobs and J. Schaller.
    Sodium meclofenamate (Meclomen) in the treatment of juvenile rheumatoid arthritis. A segment I study.
    J Rheumatol, 9 129-134 (), 1982. [ http ]

 

  • E. Brewer, E. Giannini, J. Baum, C. Fink, V. Hanson, J. Jacobs and J. Schaller.
    Proquazone (Biarsan) in the treatment of juvenile rheumatoid arthritis. A segment I study.
    J Rheumatol, 9 135-139 (), 1982. [ http ]

 

  • J. Bass, E. Giannini, E. Brewer, B. Athreya, N. Brandstrup, D. Goldsmith, J. Miller and L. Pachman.
    Pirprofen (Rengasil) in the treatment of juvenile rheumatoid arthritis. A segment I study.
    J Rheumatol, 9 140-3 (1), 1982. [ http ]

 

  • E. J. Brewer and E. H. Giannini.
    Standard methodology for Segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. I. Design.
    J Rheumatol, 9 109-13 (1), 1982. [ http ]

 

  • E. H. Giannini and E. J. Brewer.
    Standard methodology for Segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. II. Analysis and presentation of data
    J Rheumatol, 9 114-122 (1), 1982. [ http ]

 

  • E. J. Brewer, E. H. Giannini, J. Baum, B. Bernstein, C. W. Fink, H. M. Emery and J. G. Schaller.
    Aspirin and fenoprofen (Nalfon) in the treatment of juvenile rheumatoid arthritis results of the double blind-trial. A segment II study
    J Rheumatol, 9 123-128 (1), 1982. [ http ]

 

  • E. J. Brewer, E. H. Giannini, J. Baum, B. Bernstein, C. W. Fink, J. G. Schaller and C. M. Knee.
    Ketoprofen (Orudis) in the treatment of juvenile rheumatoid arthritis. A segment I study
    J Rheumatol, 9 144-148 (1), 1982. [ http ]

 

  • E. Brewer, R. Nickeson, R. Rossen, D. Person, E. Giannini and J. Milam.
    Plasma exchange in selected patients with juvenile rheumatoid arthritis.
    J Pediatr, 98 194-200 (), 1981. [ http ]

 

  • E. Brewer, E. Giannini and E. Barkley.
    Gold Therapy in the Management of Juvenile Rheumatoid Arthritis
    Arthritis Rheum, 23 404-411 (), 1980. [ http ]

 

  • E. Brewer, E. Giannini, R. Rossen, B. Patten and E. Barkley.
    Plasma exchange therapy of a childhood onset dermatomyositis patient.
    Arthritis Rheum, 23 509-513 (), 1980. [ http ]

 

  • J. Levinson, J. Baum, E. Brewer Jr, C. Fink, V. Hanson and J. Schaller.
    Comparison of tometin sodium and aspirin in the treatment of juvenile rheumatoid arthritis
    J Pediatr, 91 799-804 (5), 1977. [ http ]